您的当前位置:首页 > 行业数据 > JSKN003治疗HER2阳性(IHC3+)实体瘤临床结果表现出良好的耐受性、安全性和抗肿瘤活性
图片属性
图片格式:PNG 图片大小:255KB 图片尺寸:2327*909
同报告图片
 / 4
JSKN003治疗HER2阳性(IHC3+)实体瘤临床结果表现出良好的耐受性、安全性和抗肿瘤活性_第1页
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
JSKN003治疗HER2阳性(IHC3+)实体瘤临床结果表现出良好的耐受性、安全性和抗肿瘤活性_第2页
JSKN003治疗HER2阳性(IHC3+)实体瘤临床结果表现出良好的耐受性、安全性和抗肿瘤活性_第3页
JSKN003治疗HER2阳性(IHC3+)实体瘤临床结果表现出良好的耐受性、安全性和抗肿瘤活性_第4页
JSKN003治疗HER2阳性(IHC3+)实体瘤临床结果表现出良好的耐受性、安全性和抗肿瘤活性_第5页
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
所属报告: 【开源证券】港股公司首次覆盖报告:研发实力雄厚,多项重磅出海交易即将达成-250919(34页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠